Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Diabetes mellitus (DM) and tuberculosis (TB) are two common diseases with increasing geographic overlap and clinical interactions. The effect of DM and hemoglobin A1c (HbA1c) values on the pharmacokinetics (PK) and pharmacodynamics (PD) of anti-TB drugs remains poorly characterized. Newly diagnosed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Alfarisi, Omamah, Mave, Vidya, Gaikwad, Sanjay, Sahasrabudhe, Tushar, Ramachandran, Geetha, Kumar, Hemanth, Gupte, Nikhil, Kulkarni, Vandana, Deshmukh, Sona, Atre, Sachin, Raskar, Swapnil, Lokhande, Rahul, Barthwal, Madhusudan, Kakrani, Arjun, Chon, Sandy, Gupta, Amita, Golub, Jonathan E., Dooley, Kelly E.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201087/
https://ncbi.nlm.nih.gov/pubmed/30126955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01383-18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares